Validity of single tract microelectrode recording in subthalamic nucleus stimulation

Neurol Med Chir (Tokyo). 2013;53(11):821-7. doi: 10.2176/nmc.oa2012-0412. Epub 2013 Oct 21.

Abstract

In surgery for subthalamic nucleus (STN) deep brain stimulation (DBS), precise implantation of the lead into the STN is essential. Physiological refinement with microelectrode recording (MER) is the gold standard for identifying STN. We studied single tract MER findings and surgical outcomes and verified our surgical method using single tract MER. The number of trajectories in MER and the final position of lead placement were retrospectively analyzed in 440 sides of STN DBS in 221 patients. Bilateral STN DBS yielded marked improvement in the motor score, dyskinesia/fluctuation score, and reduced requirement of dopaminergic medication in this series. The number of trajectories required to obtain sufficient activity of the STN was one in 79.0%, two in 18.2%, and three or more in 2.5% of 440 sides. In 92 sides requiring altered trajectory, the final direction of trajectory movement was posterior in 73.9%, anterior in 13.0%, lateral in 5.4%, and medial in 4.3%. In 18 patients, posterior moves were required due to significant brain shift with intracranial air caused by outflow of CSF during the second side procedure. Sufficient STN activity is obtained with minimum trajectories by proper targeting and precise interpretation of MER findings even in the single tract method. Anterior-posterior moves rather than medial-lateral moves should be attempted first in cases with insufficient recording of STN activity.

Publication types

  • Validation Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Combined Modality Therapy
  • Deep Brain Stimulation / instrumentation
  • Deep Brain Stimulation / methods*
  • Dopamine Agonists / therapeutic use
  • Electrodes, Implanted*
  • Electroencephalography / instrumentation
  • Electroencephalography / methods*
  • Female
  • Humans
  • Male
  • Microelectrodes*
  • Middle Aged
  • Parkinson Disease / drug therapy
  • Parkinson Disease / physiopathology
  • Parkinson Disease / therapy*
  • Psychomotor Performance
  • Retrospective Studies
  • Severity of Illness Index
  • Subthalamic Nucleus / physiopathology*
  • Treatment Outcome

Substances

  • Dopamine Agonists